JUL 22, 2019 09:45 AM PDT

Don't Combine Breast and Gyno Surgery, Study Advises

WRITTEN BY: Julia Travers

Surgeries can be stressful and difficult for patients, and it’s understandable that some would want to reduce the number of days they need to devote to surgical procedures. This desire has led some women to choose to combine breast and gynecologic procedures, such as cancer-preventive breast surgeries, hysterectomy and/or ovarian removal, into a single hospital visit. But, a new study out of the University of Colorado (CU) Cancer Center recently published in Breast Journal advises against this practice. This recommendation is based on an analysis of data from the National Surgery Quality Improvement Program (NSQIP) database.

The researchers involved found several negative trends associated with doubling up on these surgeries, including higher complication, readmission, and reoperation rates, a much longer length of stay at the hospital (compared to patients who had a single site surgery). These findings were drawn from the records of 77,030 women who had breast surgery between 2011 and 2015, 124 of whom also had a gynecologic surgery at the same time. Usually, younger women made this choice, but this group still showed the higher rate of surgery complications. 

“In patients at high risk of developing breast cancer and ovarian cancer, we recommend doing the prophylactic bilateral mastectomy along with breast reconstruction, but then trying to keep gynecologic surgery separate. It's safer and easier to do them separately," Dr. Sarah Tevis, CU Cancer Center investigator and breast surgeon at UC Health University of Colorado Hospital, told EurekAlert

Treatment delays tied to scheduling difficulties are also sometimes associated with combining surgical procedures. And, complications can delay the start of chemo for some patients, which has further ramifications. 

Tevis points out that, for some patients, a medical condition may make combining surgeries and only undergoing anesthesia once preferable. But she describes these cases as “rare.” Further research on these topics will attempt to identify which women will have better or worse reactions to the various surgical scheduling approaches. 

Article source: EurekAlert

About the Author
  • Julia Travers is a writer, artist and teacher. She frequently covers science, tech and conservation.
You May Also Like
JAN 23, 2020
Cancer
JAN 23, 2020
Not worth the risk: e-cigs and lung inflammation
E-cigarette use is on the rise and according to new research published in the journal Cancer Prevention Research, even short-term usage of e-cigs can be a ...
JAN 23, 2020
Cancer
JAN 23, 2020
What can we do about the financial hardships of cancer?
Have you ever had the unfortune of getting out of the hospital and later receiving a medical bill for which you were completely unprepared? Even if you hav...
JAN 23, 2020
Cancer
JAN 23, 2020
Diet and prostate cancer
It is difficult to pinpoint a specific diet to its benefits or detriments, largely because so many other factors often go along with diet. For example, it ...
JAN 23, 2020
Cancer
JAN 23, 2020
How HPV might actually defend against skin cancer
New research from scientists at Massachusetts General Hospital features findings that suggest that immunity to certain strains of HPV (human papillomavirus...
JAN 23, 2020
Drug Discovery & Development
JAN 23, 2020
The Side-Effects to A Common Blood Cancer Drug
In a study published in Scientific Reports, a popular cancer drug, known as ruxolitnib, was found to cause an increased weight gain as well as an increase ...
JAN 23, 2020
Genetics & Genomics
JAN 23, 2020
Epigenetic Changes Make Breast Cancer Cells Drug Resistant
Researchers have found that changes in the structure of the genome in breast cancer cells can make them resistant to drug therapies....
Loading Comments...